文献速递肝病

门窦血管性疾病的遗传易感性:一项基于功能基因组学的多代家系研究

Genetic predisposition to porto-sinusoidal vascular disorder: A functional genomic-based, multigenerational family study.
PubMed 文献 · Hepatology · 2022-09-03

对黎巴嫩一个多代门窦血管性疾病(PSVD)家系中4例患者和2名健康个体进行基因组测序,发现FCHSD1基因杂合有害变异c.547C>T(p.R183W)与疾病共分离,提示常染色体显性遗传伴表现度差异。功能分析显示该变异增加FCHSD1 mRNA稳定性、蛋白过表达及mTORC1激活;将人FCHSD1R183W变异通过CRISPR/Cas9引入小鼠后,15只携带该变异的小鼠中9只出现脾大和门静脉增宽,模拟人类PSVD表型。结论认为FCHSD1结构和功能异常导致mTOR通路过度激活,可能引起PSVD。

要点

  • 在一个黎巴嫩PSVD家系中发现FCHSD1基因杂合变异c.547C>T(p.R183W)与疾病共分离。
  • FCHSD1R183W增加mRNA稳定性、蛋白过表达及mTORC1激活。
  • 15只携带人FCHSD1R183W变异的小鼠中9只出现脾大和门静脉增宽。

核心结论

  • FCHSD1结构和功能异常导致mTOR通路过度激活,可能引起PSVD。

研究设计与样本

  • 对黎巴嫩一个多代PSVD家系中4例患者和2名健康个体进行基因组测序。
  • 将人FCHSD1R183W变异通过CRISPR/Cas9基因组编辑引入小鼠。

主要发现

  • 在患者中鉴定出FCHSD1基因杂合有害变异c.547C>T(p.R183W),该变异与疾病共分离,遗传模式提示常染色体显性伴表现度差异。
  • RNA结构建模提示547位C-to-T替换(对应FCHSD1R183W)可能增加mRNA和蛋白稳定性及其与MTOR相关蛋白LST8同源物的相互作用。
  • 生化分析显示FCHSD1R183W诱导高FCHSD1 mRNA稳定性、FCHSD1蛋白过表达和mTORC1激活增加。
  • 15只携带人FCHSD1R183W变异的小鼠中9只模拟人类PSVD表型,包括脾大和门静脉增宽。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Porto-sinusoidal vascular disorder (PSVD) is a group of liver vascular diseases featuring lesions encompassing the portal venules and sinusoids unaccompanied by cirrhosis, irrespective of the presence/absence of portal hypertension. It can occur secondary to coagulation disorders or insult by toxic agents. However, the cause of PSVD remains unknown in most cases. Hereditary cases of PSVD are exceptionally rare, but they are of particular interest and may unveil genetic alterations and molecular mechanisms associated with the disease. APPROACH AND RESULTS: We performed genome sequencing of four patients and two healthy individuals of a large multigenerational Lebanese family with PSVD and identified a heterozygous deleterious variant (c.547C>T, p.R183W) of FCH and double SH3 domains 1 ( FCHSD1 ), an uncharacterized gene, in patients. This variant segregated with the disease, and its pattern of inheritance was suggestive of autosomal dominant with variable expressivity. RNA structural modelling of human FCHSD1 suggests that the C-to-T substitution at position 547, corresponding to FCHSD1R183W , may increase both messenger RNA (mRNA) and protein stability and its interaction with MTOR-associated protein, LST8 homolog, a key protein of the mechanistic target of rapamycin (mTOR pathway). These predictions were substantiated by biochemical analyses, which showed that FCHSD1R183W induced high FCHSD1 mRNA stability, overexpression of FCHSD1 protein, and an increase in mTORC1 activation. This human FCHSD1 variant was introduced into mice through CRISPR/Cas9 genome editing. Nine out of the 15 mice carrying the human FCHSD1R183W variant mimicked the phenotype of human PSVD, including splenomegaly and enlarged portal vein. CONCLUSIONS: Aberrant FCHSD1 structure and function leads to mTOR pathway overactivation and may cause PSVD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Shan J, Megarbane A, Chouchane A, et al. Genetic predisposition to porto-sinusoidal vascular disorder: A functional genomic-based, multigenerational family study. Hepatology. 2022. PMID: 35989577. doi:10.1002/hep.32735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。